Development of 5-nitrothiazole derivatives: Identification of leads against both replicative and latent Mycobacterium tuberculosis

Bioorganic & Medicinal Chemistry Letters
2012.0

Abstract

Twenty eight 5-nitrothiazole derivatives were synthesized and evaluated for in vitro activities against Mycobacterium tuberculosis (MTB), cytotoxicity against HEK 293T. Among the compounds, 5-nitro-N-(5-nitrothiazol-2-yl)furan-2-carboxamide (20) was found to be the most active compound in vitro with MICs of 5.48 μM against log-phase culture of MTB and also non-toxic up to 100 μM.

Knowledge Graph

Similar Paper

Development of 5-nitrothiazole derivatives: Identification of leads against both replicative and latent Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2012.0
5-Nitrofuran-2-yl derivatives: Synthesis and inhibitory activities against growing and dormant mycobacterium species
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H37RV
Bioorganic & Medicinal Chemistry Letters 2011.0
Heterocyclic benzazole derivatives with antimycobacterial In vitro activity
Bioorganic & Medicinal Chemistry Letters 2002.0
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents
Bioorganic & Medicinal Chemistry Letters 2016.0
Searching for New Cures for Tuberculosis: Design, Synthesis, and Biological Evaluation of 2-Methylbenzothiazoles
Journal of Medicinal Chemistry 2009.0
New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents
Bioorganic & Medicinal Chemistry Letters 2014.0
Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors
European Journal of Medicinal Chemistry 2019.0
Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates
Bioorganic & Medicinal Chemistry Letters 2006.0
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and NonreplicatingMycobacterium tuberculosis
Journal of Medicinal Chemistry 2016.0